<DOC>
	<DOCNO>NCT01039142</DOCNO>
	<brief_summary>In study , investigator intend compare efficacy safety various dos acitretin randomize double blind manner patient severe plaque-type psoriasis , ) study change PASI score baseline measure efficacy ii ) determine frequency side effect various dos . Sixty patient recruited Psoriasis Clinic Department Dermatology , Venerology Leprology , PGIMER . Patients randomly assign one three group : Group A , consist 20 patient , administer acitretin 25 mg/ day , Group B , consist 20 patient , administer acitretin 35 mg/day GROUP C consist 20 patient , administer acitretin 50 mg/day This therapy continue PSORIASIS AREA AND SEVERITY INDEX ( PASI ) score reduce &lt; 25 % original score 12 week , whichever come earlier . It expect acitretin high dose efficacious . As exact etiopathogenesis psoriasis fully know , difficult provide definite cure patient , though disease activity control great extent various treatment modality . However dosage acitretin adjust accord response patient tolerability side effect .</brief_summary>
	<brief_title>Dose Ranging Study Assess Efficacy Safety Acitretin Severe Plaque Type Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<criteria>Patients plaquetype psoriasis &lt; 90 % body surface area involvement , whose disease activity stable last 1month . Age range 1865 year either sex Females postmenopausal tubectomised complete family willing maintain contraception 1 month , 2 year completion treatment negative pregnancy test within 2 month start treatment . Compliance schedule visit . Patients severe hepatic , renal systemic disorder ( serum bilirubin , AST , ALT alkaline phosphatase &gt; 1.5 time upper limit normal ; serum creatinine &gt; 1.5 mg % males &gt; 1.4mg % female ) Pregnant lactate woman , contemplate pregnancy next 2 3 year Alcoholic Metabolic disorder hyperlipidemia Obese/BMIâ‰¥ 30 kg/m2 Ischemic heart disease , neuropsychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Psoriasis</keyword>
</DOC>